探索DRG系统下的子宫纤维瘤不同治疗方式的成本影响
Kun Tan1, Linya Huang1, Yuxian Nie2
1Sichuan Provincial Health Information Center, Chengdu, Sichuan, China.
Frontiers in public health
|December 11, 2025
概括
高强度聚焦超声波 (HIFU) 对于子宫肌瘤,与传统手术相比,降低了住院时间和成本,特别是没有并发症. 诊断相关群体 (DRG) 系统有效地反映了这些资源差异.
科学领域:
- 医学经济学 医学经济学
- 医疗保健服务研究 医疗服务研究
- 妇科瘤学 妇科瘤学
背景情况:
- 子宫纤维瘤 (ICD-10:D25) 是常见的,需要有效的治疗策略.
- 诊断相关组 (DRG) 系统对于医疗保健成本管理和资源分配至关重要.
- 高强度聚焦超声波 (HIFU) 是传统手术干预的最小侵入性替代方案.
研究的目的:
- 为了比较HIFU和子宫纤维瘤传统手术之间的医疗资源消耗和成本.
- 评估MS-DRG群组在分类并发症或并发症 (CC/MCC) 和没有并发症或并发症的患者中的有效性.
- 确定关键的成本驱动因素,并为DRG支付改革和治疗方式选择提供信息.
主要方法:
- 分析来自四川省医院的住院病历 (2016-2024年).
- MS-DRG分类和XGBoost建模用于HIFU患者数据重新分类.
- 多因素回归分析,以确定影响成本的因素.
主要成果:
- 在非CC/MCC患者中,HIFU显著降低了停留时间 (LOS) 和耗材/药物成本的比例.
- 在CC/MCC组中,医院住院成本的中位数更高.
- LOS,HIFU处理和CC/MCC分组被确定为主要的成本驱动因素.
结论:
- DRG的分组有效地反映了HIFU和传统外科手术之间的资源消耗差异.
- HIFU技术显示出在子宫纤维瘤治疗中优化医疗资源分配的潜力.
- 促进HIFU,优化保险政策和加强医院管理可以改善成本控制和医疗保健质量.
更多相关视频
相关概念视频
Varicose Veins II: Diagnostic Studies and Interprofessional Care
164
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
164
Drugs for Treatment of Diarrhea-Predominant IBS
598
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
598


